The FRAMES Clinical Study in FRDA
- The FRAMES Clinical Study in FRDA
The FRAMES trial is a phase 2 randomized, double-blind, placebo-controlled, clinical study that has been designed to assess the efficacy and safety of leriglitazone in patients with Friedreich's ataxia (FRDA).This study has been designed with input from EU and US clinical experts and patient advocacy groups.
Recruitment of over 30 patients in the FRAMES study has been completed and results are anticipated by the end of 2020.
For further information visit:
https://clinicaltrials.gov/ct2/show/NCT03917225?term=MIN102&rank=2Hospitals involved in FRAMES Clinical StudySee mapHôpital Erasme-ULBBrusselsBelgiumICM, Groupe Hospitalier Pitié SalpêtrièreParisFranceUniversitätsklinikum RWTHAachenGermanyHospital Universitario La PazMadridSpainHospital Sant Joan de DéuBarcelonaSpainHospitals involved in FRAMES Clinical StudySee list
Hôpital Erasme-ULBBrusselsBelgiumICM, Groupe Hospitalier Pitié SalpêtrièreParisFranceUniversitätsklinikum RWTHAachenGermanyHospital Universitario La PazMadridSpainHospital Sant Joan de DéuBarcelonaSpain
- Contact
Feel free to contact us in case you are interested in any of these clinical studies